Stocks and Investing
Stocks and Investing
Tue, March 22, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 21, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Jeffrey Zekauskas Upgraded (APD) to Buy and Held Target at $275 on, Mar 21st, 2022
Jeffrey Zekauskas of JP Morgan, Upgraded "Air Products and Chemicals, Inc." (APD) to Buy and Held Target at $275 on, Mar 21st, 2022.
Jeffrey has made no other calls on APD in the last 4 months.
There are 9 other peers that have a rating on APD. Out of the 9 peers that are also analyzing APD, 4 agree with Jeffrey's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John McNulty of "BMO Capital" Downgraded from Buy to Hold on, Tuesday, February 8th, 2022
- Steve Byrne of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $285 on, Monday, February 7th, 2022
- Josh Silverstein of "Wolfe Research" Downgraded from Buy to Hold and Held Target at $331 on, Thursday, December 9th, 2021
- Stephen Richardson of "Evercore ISI Group" Downgraded from Buy to Hold and Held Target at $330 on, Tuesday, December 7th, 2021
These are the ratings of the 5 analyists that currently disagree with Jeffrey
- Christopher Parkinson of "Mizuho" Maintained at Strong Buy with Decreased Target to $312 on, Monday, February 7th, 2022
- David Begleiter of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $300 on, Monday, February 7th, 2022
- Marc Bianchi of "TD Cowen" Maintained at Buy with Decreased Target to $345 on, Monday, February 7th, 2022
- Michael Sison of "Wells Fargo" Maintained at Buy with Decreased Target to $325 on, Monday, February 7th, 2022
- Kevin McCarthy of "Vertical Research" Upgraded from Hold to Strong Buy and Held Target at $335 on, Tuesday, January 4th, 2022
Contributing Sources